These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 17349047)
1. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047 [TBL] [Abstract][Full Text] [Related]
2. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Rakha EA; Boyce RW; Abd El-Rehim D; Kurien T; Green AR; Paish EC; Robertson JF; Ellis IO Mod Pathol; 2005 Oct; 18(10):1295-304. PubMed ID: 15976813 [TBL] [Abstract][Full Text] [Related]
3. Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features. Wang RQ; Fang DC J Clin Pathol; 2003 May; 56(5):378-84. PubMed ID: 12719460 [TBL] [Abstract][Full Text] [Related]
4. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer. Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059 [TBL] [Abstract][Full Text] [Related]
5. Expression of epithelial mucins Muc1, Muc2, and Muc3 in ductal carcinoma in situ of the breast. Diaz LK; Wiley EL; Morrow M Breast J; 2001; 7(1):40-5. PubMed ID: 11348414 [TBL] [Abstract][Full Text] [Related]
6. Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance. Sierzega M; Młynarski D; Tomaszewska R; Kulig J Histopathology; 2016 Oct; 69(4):582-91. PubMed ID: 27165582 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. Xi HQ; Zhao P J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057 [TBL] [Abstract][Full Text] [Related]
8. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. Bae JM; Lee TH; Cho NY; Kim TY; Kang GH World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765 [TBL] [Abstract][Full Text] [Related]
9. MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor. Genitsch V; Zlobec I; Thalmann GN; Fleischmann A Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):242-7. PubMed ID: 27165976 [TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients. Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720 [TBL] [Abstract][Full Text] [Related]
11. Improving patient survival with the colorectal cancer multi-disciplinary team. MacDermid E; Hooton G; MacDonald M; McKay G; Grose D; Mohammed N; Porteous C Colorectal Dis; 2009 Mar; 11(3):291-5. PubMed ID: 18477019 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients. Yu MH; Luo Y; Qin SL; Zhong M Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586 [TBL] [Abstract][Full Text] [Related]
13. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N Oncology; 1998; 55(4):307-19. PubMed ID: 9663420 [TBL] [Abstract][Full Text] [Related]
14. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival. Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer. Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222 [TBL] [Abstract][Full Text] [Related]
16. Tumour budding at invasive margins and outcome in colorectal cancer. Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of mucin 1 and mucin 2 in colorectal cancer. Kasprzak A; Siodła E; Andrzejewska M; Szmeja J; Seraszek-Jaros A; Cofta S; Szaflarski W World J Gastroenterol; 2018 Sep; 24(36):4164-4177. PubMed ID: 30271081 [TBL] [Abstract][Full Text] [Related]
18. MUC1 and MUC5AC implication in Tunisian colorectal cancer patients. Hazgui M; Weslati M; Boughriba R; Ounissi D; Bacha D; Bouraoui S Turk J Med Sci; 2021 Feb; 51(1):309-318. PubMed ID: 32967412 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues. Pak MG; Koh HJ; Roh MS Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229 [TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis. Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]